Stockreport

Is BridgeBio Pharma (BBIO) Pricing Reflect Long Term Potential After 156.5% One Year Surge [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF The stock trades at US$73.99, with returns of 156.5% over 1 year and a very large gain over 3 years, while the year-to-date return of a 5.4% decline and a flat 0.5% ret [Read more]